methamphetamine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artner, I; Asplund, O; Bock, C; Cinquina, V; Farlik, M; Gernedl, V; Groop, L; Hannes, S; Harkany, T; Hökfelt, TG; Keimpema, E; Korchynska, S; Krassnitzer, M; Lubec, G; Malenczyk, K; Mulder, J; Petersen, J; Pifl, C; Pollak, DD; Prasad, RB; Rehman, S; Reisinger, SN; Romanov, RA; Schachenhofer, J; Tretiakov, EO; Zambon, A | 1 |
| Chung, JH; Hernandez Conte, A; LaBounty, T; Lubin, L; Padilla, C; Ramzy, D; Zeng, Y | 1 |
2 other study(ies) available for methamphetamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Life-long impairment of glucose homeostasis upon prenatal exposure to psychostimulants.
Topics: Animals; Central Nervous System Stimulants; Diabetes Mellitus, Type 2; DNA Methylation; Female; Gene Expression Profiling; Gene Expression Regulation; Glucose; Glucose Intolerance; Homeostasis; Humans; Islets of Langerhans; Male; Maternal Exposure; Methamphetamine; Mice; Pregnancy; Prenatal Exposure Delayed Effects | 2020 |
Utilization of "Stand-By" Extracorporeal Membrane Oxygenation in a High-Risk Parturient With Methamphetamine-Associated Cardiomyopathy Undergoing Dilation and Evacuation: A Case Report.
Topics: Abortion, Therapeutic; Adult; Cardiomyopathies; Central Nervous System Stimulants; Diabetes Mellitus, Type 2; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension; Methamphetamine; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Triplet; Ventricular Dysfunction, Left | 2017 |